NEW
Entresto

Entresto Indications/Uses

sacubitril + valsartan

Manufacturer:

Novartis

Distributor:

Zuellig Pharma
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Entresto is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal.
Clinical judgment should be used in deciding whom to treat as LVEF is a variable measure.
Entresto is administered in place of an ACE inhibitor or ARB.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in